Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis

Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis

Objectives: This study aimed to evaluate the risk of venous thrombosis (VTE) associated with Janus kinase (JAK) inhibitors in patients diagnosed with immune-mediated inflammatory diseases.Methods: We conducted a comprehensive search of PUBMED, Cochrane, and Embase databases for randomized controlled...

Full description

Bibliographic Details
Main Authors: Juqi Zhang, Wenhui Li, Mingli Gong, Yanlun Gu, Hanxu Zhang, Bingqi Dong, Qi Guo, Xiaocong Pang, Qian Xiang, Xu He, Yimin Cui
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Pharmacology
Subjects:
janus kinase inhibitor
venous thromboembolism
inflammatory immune diseases
meta-analysis topic: venous thromboembolism
deep vein thrombosis
pulmonary embolism
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1189389/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1189389/full

Similar Items